Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Biochemistry|October 4, 2014
Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanismR Hunter Lindsey, MaryJean Pendleton, Rachel E Ashley, et al.Helvetica Chimica Acta|February 5, 2013
Synthesis and Characterization of a Novel Diels - Alder Adduct of CodeineChristopher W Cunningham, Kellie Hom, Chayan Acharya, et al.Bioorganic & Medicinal Chemistry|October 9, 2020
Synthesis and evaluation of etoposide and podophyllotoxin analogs against topoisomerase IIα and HCT-116 cellsMatthew B Murphy, Priyanka Kumar, Amber M Bradley, et al.Molecular Neurobiology|February 11, 2014
Sterol carrier protein-2: binding protein for endocannabinoidsElizabeth Sabens Liedhegner, Caleb D Vogt, Daniel S Sem, et al.Metabolism: Clinical and Experimental|March 1, 2011
Moderate-intensity endurance exercise prevents short-term starvation-induced intramyocellular lipid accumulation but not insulin resistanceJackson G Green, Nathan A Johnson, Toos Sachinwalla, et al.Metabolism: Clinical and Experimental|April 29, 2010
Low-carbohydrate diet does not affect intramyocellular lipid concentration or insulin sensitivity in lean, physically fit men when protein intake is elevatedJackson G Green, Nathan A Johnson, Toos Sachinwalla, et al.Molecular Pharmaceutics|June 19, 2010
Uptake, distribution and diffusivity of reactive fluorophores in cells: implications toward target identificationChristopher W Cunningham, Archana Mukhopadhyay, Gerald H Lushington, et al.Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.Psychopharmacology|August 22, 2020
Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonistSanjana Mada, Lisa R Gerak, Amélie Soyer, et al.Bioorganic & Medicinal Chemistry Letters|December 25, 2016
Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligandsJason R Healy, Padmavani Bezawada, Nicholas W Griggs, et al.Pageof 5